Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Pet Obesity Management Market

Pet Obesity Management Market Trends

Report ID: GMI6235
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

Pet Obesity Management Market Trends

Increasing incidence of obesity among pets will significantly drive the industry evolution. In 2022, as per the Association for Pet Obesity Prevention estimates, 59% of dogs and 61% of cats were classified as overweight or obese. Overweight pets are susceptible to various diseases that include diabetes and liver disease. These conditions might be fatal if left untreated. Therefore, increasing incidence of obese pet population are at high risk of developing diabetes.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for pet obesity management accounted for USD 810.7 million in 2022 and will grow at 7% CAGR through 2032, backed by the increasing adoption of pet for companionship, coupled with rising pet healthcare expenditure.

The dogs segment is expected to register USD 828.3 million market revenue by end of 2032 as obesity pose significant health risks for dogs, such as higher susceptibility to diabetes, joint problems, cardiovascular, and respiratory issues.

North America market accounted for 42.8% share in 2022 and will grow at considerable rate attributed to the increasing adoption of pets and rising awareness regarding pet obesity management.

Major industry players are Royal Canin, Pedigree, Zoetis Inc, Nestlé Purina among others.